Wall Street Experts
ver. ZuMIgo(08/25)
Cogent Biosciences, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 6
EBIT TTM (mln): -261
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
3 |
6 |
8 |
10 |
22 |
8 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
112.8% |
31.5% |
16.4% |
131.1% |
-65.0% |
-100.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
100.0% |
100.0% |
100.0% |
100.0% |
99.8% |
99.7% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-7 |
-19 |
-26 |
-36 |
-32 |
-82 |
-76 |
-148 |
-208 |
-276 |
EBIT Δ r/r |
0.0% |
189.3% |
37.1% |
37.7% |
-10.6% |
155.5% |
-8.1% |
95.7% |
40.8% |
32.6% |
EBIT (%) |
-220.8% |
-300.1% |
-312.8% |
-369.9% |
-143.0% |
-1044.3% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
EBITDA (mln) |
-6 |
-18 |
-25 |
-35 |
-32 |
-90 |
-75 |
-148 |
-205 |
-276 |
EBITDA(%) |
-214.8% |
-287.0% |
-298.8% |
-356.3% |
-143.0% |
-1139.5% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
-0 |
-0 |
1 |
-2 |
-8 |
-0 |
-8 |
0 |
0 |
Zysk Netto (mln) |
-7 |
-18 |
-25 |
-35 |
-30 |
-66 |
-72 |
-133 |
-192 |
-256 |
Zysk netto Δ r/r |
0.0% |
174.9% |
40.7% |
35.5% |
-12.3% |
119.5% |
8.1% |
84.7% |
45.1% |
33.0% |
Zysk netto (%) |
-220.8% |
-285.2% |
-304.9% |
-354.8% |
-134.6% |
-844.3% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
-1.13 |
-3.1 |
-3.45 |
-5.55 |
-3.97 |
-6.0 |
-1.85 |
-2.26 |
-2.42 |
-3.49 |
EPS (rozwodnione) |
-0.89 |
-2.45 |
-3.45 |
-5.55 |
-3.97 |
-6.0 |
-1.85 |
-2.26 |
-2.42 |
-3.49 |
Ilośc akcji (mln) |
6 |
6 |
7 |
6 |
8 |
11 |
39 |
59 |
80 |
73 |
Ważona ilośc akcji (mln) |
7 |
7 |
7 |
6 |
8 |
11 |
39 |
59 |
80 |
73 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |